Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS
Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler
Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler
View: Text | PDF
Research Article Genetics Neuroscience

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS

  • Text
  • PDF
Abstract

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by mutations in the survival motor neuron 1 (SMN1) gene leading to decreased SMN protein levels and motor neuron dysfunction. SMN-restoring therapies offer clinical benefit, but the downstream molecular consequences of SMN reduction remain incompletely understood. SMN deficiency resulted in downregulation of kinesin heavy chain isoform 5A (KIF5A) in human neurons and in a mouse model of SMA. SMN associated with KIF5A mRNA and contributed to its stability. Reduced SMN levels impaired axon regeneration, which was rescued by KIF5A overexpression. Because KIF5A has also been connected to ALS, these findings provide evidence of a molecular link between SMA and ALS pathophysiology, highlighting KIF5A as an SMN-regulated factor. Our findings suggest that SMN-independent interventions targeting KIF5A could represent a complementary therapeutic approach for SMA and other motor neuron diseases.

Authors

Tetsuya Akiyama, Yi Zeng, Caiwei Guo, Olivia Gautier, Lauren Koepke, Heankel Lyons, Elana Molotsky, Juliane S. Bombosch, Odilia Sianto, Jay P. Ross, Phuong Hoang, Luke Zhao, Cole Spencer, Charlotte J. Sumner, Michelle Monje, John W. Day, Aaron D. Gitler

×

Figure 5

SMN contributes to KIF5A mRNA stability through 3′-UTR–dependent mechanism.

Options: View larger image (or click on image) Download as PowerPoint
SMN contributes to KIF5A mRNA stability through 3′-UTR–dependent mechani...
The relationship between SMN protein levels and KIF5A mRNA stability was investigated. (A) Experimental schematic. At 12 days after induction, SMN knockdown (SMN-KD) and scrambled control (SCR) i3Ns were collected for the assays shown in panels B and E–H. (B) SMN-KD and SCR i3Ns were treated with actinomycin D (Act-D, 10 μg/mL) to inhibit de novo RNA synthesis, and cells were harvested at the indicated time points for qPCR analysis. KIF5A mRNA declined more rapidly in SMN-KD neurons than in SCR controls, with differences at 3 hours and 6 hours. Statistical significance was determined by 2-way ANOVA followed by Šídák’s multiple comparisons test. n = 3 independent experiments. (C) Schematic of the dual-luciferase reporter assay used to assess UTR-dependent regulation of KIF5A expression. Luciferase reporters containing no UTR, the KIF5A 5′-UTR, or the KIF5A 3′-UTR were transfected into stable SCR or SMN-KD HEK293T cells (Supplemental Figure 6, A–C). (D) Quantification of luciferase activity. Reporter activity from control and 5′-UTR constructs was unchanged between SCR and SMN-KD cells, whereas the KIF5A 3′-UTR reduced reporter activity in SMN-KD cells. (E) Immunoprecipitation (IP) using an anti-SMN antibody confirming efficient pulldown of SMN protein from i3N lysates. (F) RNA immunoprecipitation (RIP) followed by RT-PCR analysis demonstrating preferential enrichment of KIF5A mRNA over KIF5B mRNA in SMN immunoprecipitants. (G) Schematic of the RNA pulldown assay using biotinylated 5′ and 3′-UTRs of KIF5A, KIF5B, and KIF5C incubated with i3N lysates. (H) Immunoblot analysis of RNA pulldown fractions showed recovery of SMN with KIF5A 3′-UTRs and, to a lesser extent, with the KIF5B 3′-UTR, but not with any 5′-UTRs or KIF5C UTRs. FUS was not detected. Beads-only samples without RNA (No RNA) were used as a negative control, and blank lanes contained no sample.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts